Fundz

Nyra Medical Announces $20 Million Series A Financing For Its Transcatheter Heart Valve Repair Technology

PRIVATENov 23, 2022

Amount Raised

$20 Million

Round Type

Series A

DecaturBiotechnology

Investors

The Georgia Research Alliance Venture FundEpidarex CapitalBroadview VenturesVensana Capital

Description

Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, today announced the closing of a $20 million Series A financing. The round was co-led by Vensana Capital and a large, global medical device company, alongside additional investors Broadview Ventures, Epidarex Capital, and the Georgia Research Alliance Venture Fund. Proceeds from the financing will be used to support Nyra's technology through early feasibility clinical studies.

Quick answer

Nyra Medical raised $20 Million in a Series A round, dated November 23, 2022. Investors: The Georgia Research Alliance Venture Fund, Epidarex Capital, Broadview Ventures and Vensana Capital. Nyra Medical is based in Decatur, Georgia, United States.

How much did Nyra Medical raise?
Nyra Medical raised $20 Million in a Series A round on November 23, 2022.
Who invested in Nyra Medical?
The Georgia Research Alliance Venture Fund, Epidarex Capital, Broadview Ventures and Vensana Capital are named as investors in this round.
What does Nyra Medical do?
Nyra Medical is a Atlanta, US based structural heart technology company developing a first in class technology to correct leaky heart valves by enhancing the contour of the native leaflet with an implant.
Where is Nyra Medical based and how big is it?
Nyra Medical is based in Decatur, Georgia, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Nyra Medical that raised within 45 days of this round, from Fundz verified event records.

  • MedX Health raised an undisclosed amount (Convertible Note) on January 6, 2023.
  • Vitro Biopharma raised $993K (Seed) on January 6, 2023.
  • Synthekine raised $100M (Series C) on January 6, 2023.
  • Amolyt Pharma raised $138M (Series C) on January 6, 2023.
  • Cambium Analytica raised $3.8M (Seed) on January 6, 2023.
  • Byonyks Medical Devices raised $1M (Seed) on January 6, 2023.

Who to call at Nyra Medical, and when

A new round usually means Nyra Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nyra Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nyra Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nyra Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nyra Medical

Location

2459 OAK GROVE HEIGHTS

Decatur, Georgia, United States

About

Nyra Medical is a Atlanta, US based structural heart technology company developing a first in class technology to correct leaky heart valves by enhancing the contour of the native leaflet with an implant.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nyra Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Nyra Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Nyra Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.